Results 161 to 170 of about 65,024 (264)

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients. [PDF]

open access: yesMult Scler J Exp Transl Clin, 2021
van Lierop Z   +10 more
europepmc   +1 more source

Calibration and discrimination ability of the Dat'AIDS score in people living with HIV aged 70 years and older from the Dat'AIDS cohort

open access: yesHIV Medicine, EarlyView.
Abstract Objective The Dat'AIDS score was developed to predict 5‐year mortality risk in people living with HIV aged 60 and older. However, its validity in people living with HIV aged 70 years and older needed confirmation. Methods This was a multicentre prospective cohort study in the Dat'AIDS French cohort.
Abeo Mousse   +337 more
wiley   +1 more source

Biopsy-proven PML in an HIV-negative patient with discoid lupus: Failure to detect JC virus in CSF. [PDF]

open access: yesClin Neurol Neurosurg, 2021
Villani LA   +9 more
europepmc   +1 more source

Auto‐inducible expression of chimeric antigen receptor T cells using the NR4A1 promoter

open access: yesImmunology &Cell Biology, EarlyView.
The NR4A1 promoter is a compact auto‐inducible promoter to drive CAR expression in T cells. Compared with EF1α, or existing synthetic antigen‐inducible promoters, NR4A1 is more compact and ensures that resting CAR T cells express reduced baseline CAR. NR4A1 allows rapid induction upon antigen encounter with reduced T‐cell exhaustion.
Samuel WJ Smith‐Bell   +5 more
wiley   +1 more source

Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian Centers. [PDF]

open access: yesViruses
Pocora MM   +15 more
europepmc   +1 more source

Immune‐related toxicity profile after haematopoietic stem cell transplantation in patients with B‐ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab

open access: yes
British Journal of Haematology, EarlyView.
Olayinka Okeleji   +7 more
wiley   +1 more source

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault   +51 more
wiley   +1 more source

The Role of the JC Virus in Central Nervous System Tumorigenesis. [PDF]

open access: yesInt J Mol Sci, 2020
Ahye N, Bellizzi A, May D, Wollebo HS.
europepmc   +1 more source

Home - About - Disclaimer - Privacy